Evidence map›Paper›PMID 41367836›Full record

ReviewSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Intraocular lens power calculation in challenging cases.

Jack X Ma, Li Wang, Douglas D Koch

Abstract readReview
In one paragraph

Review in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jack X MaDepartment of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.
Li WangDepartment of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.
Douglas D KochDepartment of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we reviewed recently published papers of intraocular lens (IOL) power calculation in special eyes. In short eyes, accurate estimation of effective lens position is critical, and the ZEISS artificial intelligence IOL calculator produces the best outcomes. In long eyes, accuracy has been improved with axial length (AL) adjusted formulas such as the Wang-Koch AL adjustment and newer IOL formulas. In keratoconic eyes, hyperopic refractive outcomes increase with steeper keratometric values, and accuracy is poor in eyes with keratometric values ≥50.0 D. Two keratoconus-specific formulas (Barrett True K for keratoconus and Kane keratoconus) have been introduced. In eyes undergoing combined Descemet membrane endothelial keratoplasty and cataract surgery, steeper corneas and corneas with a lower anterior/posterior ratio may have higher degrees of corneal flattening, and more myopia ranging from -0.75 to -1.0 D should be targeted. The postrefractive IOL power calculator from the American Society of Cataract and Refractive Surgery website has been a useful tool for postrefractive IOL power calculation. Recently, newer IOL formulas incorporating both anterior and posterior corneal measurements were introduced for eyes with previous corneal refractive surgery: Barrett True-K TK, Pearl-DGS, EVO 2.0, and Hoffer QST. It is recommended to obtain IOL calculations using as many formulas as possible and select the IOL power based on the consensus of multiple methods, with more weight given to the newer IOL power calculation formulas.

Indexed as

Intraocular lens power calculationkeratoconuskeratoplastylong eyespostrefractive eyesshort eyes

Identifiers

PMID41367836
PMCPMC12685263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.